Medical Training AIStem Cell Biology Fundamentals
You'll be able to explain stem cell mechanisms of action and identify the regulatory boundaries that govern their clinical use.
What this track covers
This track covers adult stem cell biology, including self-renewal, differentiation, paracrine signaling, and immunomodulation, along with the tissue sources used in regenerative practice such as adipose, bone marrow, and perinatal tissue. It also addresses the FDA regulatory framework, including 21 CFR 1271, that determines what a clinician can and cannot offer patients.
What you will practice
- Distinguish self-renewal, differentiation, and paracrine effects when explaining mechanism of action to a patient
- Compare adipose-derived, bone marrow-derived, and perinatal tissue sources by processing and regulatory category
- Identify whether a proposed use falls under minimal manipulation and homologous use as defined in 21 CFR 1271
- Recognize red flags in marketing claims that may signal noncompliant stem cell offerings
- Map a patient's regenerative medicine question to the right regulatory and clinical framework before responding
Simulator scenario
A patient asks about a stem cell injection they saw advertised online, and the clinician must assess the claim, explain the biology in plain terms, and determine whether it fits within regulatory bounds.
Board question topics
- Adult stem cell properties and mechanisms
- Tissue source comparison and processing
- 21 CFR 1271 minimal manipulation criteria
- Homologous use determination
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free